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The Human Microbiome Project defined microbial community interactions with the
human host, and provided important molecular insight into how epigenetic factors can
influence intestinal ecosystems. Given physiological context, changes in gut microbial
community structure are increasingly found to associate with alterations in enteric
neurotransmission and disease. At present, it is not known whether shifts in microbial
community dynamics represent cause or consequence of disease pathogenesis. The
discovery of bacterial-derived neurotransmitters suggests further studies are needed to
establish their role in enteric neuropathy. This mini-review highlights recent advances in
bacterial communications to the autonomic nervous system and discusses emerging
epigenetic data showing that diet, probiotic and antibiotic use may regulate enteric
neurotransmission through modulation of microbial communities. A particular emphasis
is placed on bacterial metabolite regulation of enteric nervous system function in the
intestine.
Keywords: microbiome, metabolome, neurotransmitters, nitric oxide, epigenetics, neuropathy, intestinal disease,
enteric nervous system
INTRODUCTION
The intestine has evolved efficient digestive, endocrine and immune functions in concert with its
microbiota—a vast and complex symbiotic ecosystem comprising bacteria, viruses, fungi, protozoa,
and archaea living in close proximity to the host (Bäckhed et al., 2005; Jumpstart Consortium
Human Microbiome Project Data Generation Working Group, 2012; Yatsunenko et al., 2012).
Working in synergy with these microorganisms, the gut-microbiota axis provides the host with
adequate nutrients and energy for good health, growth and reproduction. While little is known
about the virome and eukaryotic microorganisms in the gut, the human intestinal microbiota is
comprised of over 50 different bacterial phyla that are dominated by Bacteroidetes, Firmicutes, and
Actinobacteria in healthy adults (Bäckhed et al., 2005; Jumpstart Consortium Human Microbiome
Project Data Generation Working Group, 2012; Yatsunenko et al., 2012). Age is a significant
determining factor inmicrobiota composition, as is genetic hardwiring and host immune responses
that help to shape our gut microbial communities (Yatsunenko et al., 2012; Kelder et al., 2014).
Diet, probiotic, and antibiotic use also modulate intestinal microbiota composition and represent
some of the best studied examples of how epigenetic signals can potentially cause permanent
alterations to microbial community structure and function in humans (Turnbaugh et al., 2006,
2008; Yatsunenko et al., 2012; Hemarajata and Versalovic, 2013).
Epigenetics is defined as heritable changes in gene expression that occur without coding
changes in DNA sequence and often involve posttranscriptional and/or posttranslational signals
from the environment. It is increasingly appreciated that the gut microbiota can contribute
to human disease, not only as infectious agents but also by altering exposure to dietary,
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pharmacological and environmental factors that may constitute
a disease risk (Turnbaugh et al., 2006, 2008; Hemarajata and
Versalovic, 2013). Short chain fatty acids represent one of the
best studied epigenetic examples of how microbial metabolites
can modulate host function (Choi and Friso, 2010; Donohoe
et al., 2011). Short chain fatty acid producing bacteria are
especially sensitive to antibiotics and antimicrobial therapy may
directly influence epigenetics by inhibiting histone deacetylase
activity, DNA methylation status and gene transcription in
the host. Tissues immediately exposed to such microbial
metabolites are most at risk of aberrant gene regulation and
include the enteric nervous and immune systems, as well as
dysregulation of intestinal epithelial stem cells that may lead
to neoplasia (Berni Canani et al., 2012). Because microbial
drug and dietary metabolites, including bacterial and viral
immunomodulators of toll-like pattern recognition receptors,
serve as epigenetic activators of host gene expression this is an
area of intense investigation that requires a better understanding
of microbial community dynamics and altered biochemical
function associated with disease risk in humans.
Massive parallel sequencing of bacterial genes has transformed
our understanding of gut microbial community dynamics in
intestinal disease progression, where there is often an inferred
shift in bacterial taxa and function (Jumpstart Consortium
Human Microbiome Project Data Generation Working Group,
2012; Yatsunenko et al., 2012). Although, the use of next
generation sequencing technology has significantly advanced
our knowledge of the intestinal microbiome, it is also fraught
with limitations (Polz and Cavanaugh, 1998; Schloss et al.,
2011; Edgar, 2013). Bacterial ribosomal 16S RNA profiling is
inherently biased due to estimation of microbial diversity being
reliant upon a gene that varies in copy number and sequence
per microbe. Moreover, nucleic acid amplification and software
algorithms used for community structure analysis introduce
marked biases relative to the variable 16S rDNA gene region
being studied. The short DNA sequence reads generated also
make bacterial species identification difficult. Whole shotgun
genome sequencing offers certain advantages over 16S rDNA
profiling, but this technology is low throughput, expensive and
time consuming by comparison. Our own experiences strongly
support independent validation of species of interest using
complementary quantitative methods, although identification of
disease-associated microbes can prove problematic for further
study since most gut bacteria are difficult to isolate, culture and
adapt for in vivo testing. Nevertheless, these systems biology
approaches have provided important insights into how the gut-
microbiota axis may constitute a significant risk factor in diverse
human pathologies, including infection, obesity, cancer, diabetes,
autism, autoimmune, irritable, and inflammatory bowel diseases
(this list is by no means exhaustive; Sharkey and Savidge, 2014).
Given that a bacterial presence in the intestine exerts major
host physiological responses, it seems highly likely that some of
these effects involve signaling to and from the enteric nervous
system. The enteric nervous system controls virtually all known
gut functions and has evolved sophisticated regulatory circuits
to manage clinical risk factors that contribute to the disease
susceptibilities listed above (Lomax et al., 2010; Furness, 2012;
Sharkey and Savidge, 2014). Whether, gut microbes directly
modulate these systems of checks and balances is not clear and
is a focus of this mini-review.
NERVOUS SYSTEM CONTROL OF
INTESTINAL FUNCTION
Enteric neuropathy and aberrant neurotransmission are common
findings in a range of intestinal diseases where significant
shifts in microbial community dynamics are also apparent.
A few well defined and/or extensively investigated examples
include opportunistic infection by enteric pathogens such as
Clostridium difficile (Savidge et al., 2011); intestinal barrier
failure and sensitization to food antigens (Devkota and Chang,
2013); colorectal cancer; imbalance in humoral and cell-mediated
immunity in inflammatory bowel diseases and necrotizing
enterocolitis (Margolis and Gershon, 2009; Lomax et al., 2010;
Knights et al., 2013); constipation and adverse stress signals
emanating from the central nervous system that contribute to
functional abdominal pain (Chen et al., 2003; Lyte et al., 2011;
Simrén et al., 2013). Disease pathogenesis may initiate at several
levels in the intestine, all of which fall under the umbrella
control of the autonomic nervous system (which includes the
enteric nervous system). The gut also receives functional signals
from central spinal, vagal, and sacral afferent terminals, although
their respective contributions vary in different regions of the
gastrointestinal tract (Lomax et al., 2010; Furness, 2012; Sharkey
and Savidge, 2014). The enteric nervous system consists primarily
of intrinsic primary afferent, motor and interneurons that are
arranged in ganglionated plexi (Sharkey and Savidge, 2014;
Lomax et al., 2010; Furness, 2012). It is also innervated by
terminals from extrinsic primary afferents, parasympathetic and
sympathetic nerves. Neuronal control of gut function is mediated
by muscarinic cholinergic, vasoactive intestinal peptide, and
nitric oxide signaling pathways (Savidge, 2011) that relay their
communications through intermediary cell types, e.g., enteric
glia (Gulbransen and Sharkey, 2012), Interstitial cells of Cajal
(Farrugia and Szurszewski, 2014), epithelial and smooth muscle
cells (Sharkey and Savidge, 2014), immune effectors cells (Wang
and Kasper, 2014) that initiate their own physiological signals.
Enteric glia are especially interesting cellular targets in the enteric
nervous system since these are highly responsive to microbial,
luminal and inflammatory signals that regulate intestinal barrier
function, immune responses, secretion and motility (Savidge
et al., 2007; Gulbransen and Sharkey, 2012; Sharkey and
Savidge, 2014; Kabouridis et al., 2015; MacEachern et al., 2015).
Moreover, using elegant targeted transgenic technology enteric
glia are emerging as active regulators of neurotransmission and
neuroplasticity in the intestine (see chapter by Gulbransen). It
is not clear whether enteric glia in mucosal sites also regulate
enteric nervous system function, but this glial population is
especially responsive to microbial signals (Kabouridis et al.,
2015) and is ideally positioned to mediate signals from the
gut lumen to neuronal primary afferents and to neuronal
plexi in submucosa and muscularis layers (Savidge et al., 2007;
MacEachern et al., 2015). The key points of this mini-review are
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highlighted in Figure 1, which also consider microbial-derived
neurotransmitters as emerging effector signals of the enteric
nervous system.
EXCITATORY SIGNALS ALONG THE
GUT-MICROBIOTA AXIS
Several studies have demonstrated profoundmicrobial influences
on enteric and central nervous systems, and visa versa (Collins
et al., 2012; Dinan and Cryan, 2012; Bienenstock et al., 2015).
Notable findings includemicrobiota-induced excitability of after-
hyperpolarization (AH) intrinsic primary afferent neurons in the
intestine, which was not observed in germfree animals lacking
gut bacteria (McVey Neufeld et al., 2013). Intrinsic primary
afferent neurons also show increased membrane polarization
and input resistance in germfree mice, and colonization
with a defined bacterial community restores normal neuronal
excitability. Emerging data from our and collaborator groups
show that similar changes in excitability can be elicited by
luminal application of microbial metabolites and toxins (Dann
et al., 2015; Koussoulas et al., 2015). Sensitized responses are
also evident peripherally in skin nerve recordings indicating that
microbial signals do not only act locally in the intestine. Recent
work indicates that calbindin-immunoreactive neurons in the
myenteric plexusmay be involved inmediating thesemicrobiota-
regulated signals (McVey Neufeld et al., 2015), but it is still not
clear which bacteria activate these neurons and how microbial
signals are relayed to the myenteric plexus since activation may
involve orchestration of signals from local non-neuronal cells.
Recent evidence suggests that action potential transmission could
relay such luminal-myenteric signals (Mao et al., 2013), as well
as nitric oxide intermediate signals which can relay mucosal
secretory signals in the opposite direction (Savidge et al., 2007;
MacEachern et al., 2015).
Recent reports identified spore-forming gut bacteria as
potential members of the microbiota community that elicit
neuronal excitability after signaling to enteroendocrine cells
in the colon (Reigstad et al., 2015; Yano et al., 2015). Short
chain fatty acids, vitamin E derived anti-oxidants and bile acids
were shown to promote serotonin synthesis in enteroendrocrine
cells (but not in enteric neurons) by inducing tryptophan
hydroxylase-1 gene expression, the major rate limiting enzyme
in the conversion of dietary tryptophan to serotonin. These host-
microbiota interactions significantly impact both local intestinal
(e.g., motility) and systemic functions (e.g., via increased
carriage of serotonin by platelets). However, it remains to be
established whether enteroendocrine cells serve as universal
FIGURE 1 | Microbial neurotransmitter crosstalk with the autonomic nervous system. As outlined in the article, a system of checks and balances operate to
regulate gut function. Abbreviations: 5-HT, serotonin; Ach, acetylcholine; CRF, corticotrophin releasing factor; EGF, epidermal growth factor; GDNF, glial cell
line-derived neurotrophic factor; LPS, lipopolysaccharide; M3, M3 muscarinic receptor; SCFA, short chain fatty acids; sIgA, secretory IgA; SNO, s-nitrosothiol; TGF,
transforming growth factor; VIP, vasoactive intestinal peptide; VPAC1, VIP and PACAP receptor 1.
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epithelial intermediates in gut-microbiota axis signaling since
microbial-derived factors can also exert direct effects on enteric
neurons and glia (Sharkey and Savidge, 2014; Kabouridis et al.,
2015). In particular, enteric glia are highly responsive to luminal
microbial signals and as such may serve as important regulators
of both enteric nervous system and mucosal homeostasis
(Savidge et al., 2007; Gulbransen and Sharkey, 2012; Kabouridis
et al., 2015; MacEachern et al., 2015). In another recent study,
microbial lipopolysaccharide and other products operating via
an alternative mechanism were shown to cross-signal between
enteric neurons and closely juxtaposed muscularis macrophages
(Muller et al., 2014). Microbial-induced secretion of colony
stimulating factor-1 by enteric neurons triggered activation of
muscularis macrophages and release of bone morphogenetic
protein 2, which modulated intestinal motility (via an unknown
mechanism).
All of these microbial signals appear to significantly
impact intestinal physiology by modulating motility and
immune function. It remains to be determined whether similar
metabolites also activate communications to the central nervous
system along the gut-brain axis. Furthermore, because gut
bacteria in mice are generally not good community models for
the human intestinal microbiota (Nguyen et al., 2015), it is not
clear whether similar interactions are also evident in the human
enteric nervous system.
It is interesting to note that the converse signals also exist.
The host is able to specifically communicate with spore forming
bacteria in the intestine using bioactive metabolites, for example
via the recently characterized CspC bile acid germinant receptor
on C. difficile spores (Francis et al., 2013). Certain primary
bile acids are able to promote spore germination (cholate),
whereas others (chenodeoxycholate) inhibit this receptor and
prevent bacterial growth (Sorg and Sonenshein, 2009). Bile
acids are therefore able to exert diverse regulatory signals that
target both microbe and host cells, e.g., by activating bile
acid G-protein coupled receptors (TGR 5) on intrinsic primary
afferent neurons (Alemi et al., 2013). Another, example of
how the host may communicate with gut bacteria is provided
by norepinephrine, the main catecholamine neurotransmitter
used by the sympathetic nervous system (Chen et al., 2003;
Freestone et al., 2008; Hughes et al., 2009; Lyte et al., 2011).
Norepinephrine also serves as a potent quorum sensing signal
(auto-inducer) in bacteria, such as Escherichia coli. Quorum
sensing is a cell-to-cell signaling mechanism used by bacteria
to communicate with each other by responding to hormone
auto-inducers. In this regard, the host nervous system may
directly communicate with microbial communities to regulate
bacterial growth, biofilm formation and virulence mechanisms,
including toxin production in the intestine. Enterohemorrhagic
E. coli and Campylobacter jejuni are examples where virulence
is regulated by catecholamines secreted either by the host or by
gut microbes themselves modulate gut function, although how
neurotransmitters released by the autonomous nervous system
reach the intestinal lumen in an active form remains to be
characterized. It remains to be determined how bacterial signals
fit into the hierarchical regulation of intestinal physiology, but it
is apparent that microbial signals must be considered as essential
elements in enteric nervous system control of gut function and
host defense.
EPIGENETIC REGULATORS OF
MICROBIAL NEUROTRANSMITTER
SIGNALS
An emerging literature now supports the idea that normal
intrinsic and extrinsic neurotransmission in the enteric nervous
system is governed, in part, by bacterial-derived metabolites.
However, with the exception of Clostridium difficile infection
where fecal microbiota transplantation and restoration of a
functional intestinal ecosystem has unequivocally demonstrated
an unparalleled clinical benefit (Centers for Disease Control
and Prevention (CDC), 2013; Sharkey and Savidge, 2014), a
direct beneficial or pathogenic role for gut microbes in other
human enteric diseases is less certain. Minor alterations in
food preferences, intestinal motility, host immune function,
prescribed drug or probiotic use in the sick can rapidly alter
microbial community dynamics in a misleading manner that is
suggestive of a disease association or benefit. Carefully, controlled
prospective clinical studies utilizing state-of-the art longitudinal
systems biology analysis are needed to address these important
issues, especially in view that maternal epigenetic signals may
already be exerting developmental disease susceptibility in the
young (Lewis et al., 2015).
Altered metabolic activity of gut microbes has been implicated
in aberrant regulation of enteric nervous system function,
and in some cases clinical symptoms may be alleviated by
altering microbial communities using prebiotics, probiotics and
antibiotics (Hemarajata and Versalovic, 2013; Koussoulas et al.,
2015). Epigenetic influences and early life stressors that adversely
affect intestinal microbiota development may have long-term
metabolic and immune consequences for human health. Notable
examples include regulation of extreme nutritional status in
obesity (Ridaura et al., 2013) and kwashiorkor disease (Smith
et al., 2013), or in antibiotic-associated disease pathogenesis
resulting from the expansion and translocation of resistant gut
bacteria e.g., vancomycin-resistant enterococcus (Garbutt et al.,
1999). High fat diets and foods enriched in biogenic amino acids
such as L-glutamate are also known to have profound effects
on both intestinal microbiota composition and nervous system
function. Furthermore, the intestine is a rich source of nitric
oxide and hydrogen sulfide neurotransmitters generated from
bacterial conversion of dietary nitrites and nitrates (Milkowski
et al., 2010), as is shown in Figure 2. E. coli is a prominent
bacterial species that generates bioactive nitric oxide in both
the small and large intestine using different oxygen dependent
mechanisms (Seth et al., 2012). Other nitrate-reducing bacteria
include Veillonella and Actinomyses spp which are active nitric
oxide producers in entero-salivary secretions (Hyde et al., 2014).
Antibiotic use during early life is also reported to have
lasting consequences on host physiology by altering intestinal
microbiota composition and function (Cox et al., 2014; Lewis
et al., 2015). This finding has been exploited for decades by
the agricultural industry to promote weight gain in livestock.
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FIGURE 2 | Microbial gaseous neurotransmitters. Schematic outline of microbial derived nitric oxide (NO), S-nitrosothiol derivatives (SNO), and hydrogen sulfide
(H2S) signals and their cross-interactions with carbon monoxide (CO) neurotransmitters in the enteric nervous system.
Potentially, harmful consequences for human health are only
now being realized. For example, primary disturbances in
microbiota composition by low dose penicillin, a β-lactam
antibiotic class most commonly prescribed to young children,
promotes excessive adiposity in adulthood that is distinct from
diet or genetic-induced obesity (Cox et al., 2014). Several
protective bacterial taxa, including Lactobacillus, were reportedly
implicated by modulating host metabolism in a manner that
may alter enteric nervous system function. This builds on earlier
reports that enteric microbes excite intrinsic primary afferent
neurons. For example, Bacteroides fragilis induces excitability
in myenteric AH neurons via signals that are linked to the
presence of polysaccharide A in its outer membrane wall (Perez-
Burgos et al., 2015). A preliminary study suggests that signaling
associated with this probiotic may confer health benefit to
gastrointestinal symptoms and behavior in individuals with
autism spectrum disorders. Similarly, Lactobacillus reuteri is a
probiotic bacterium that enhances colonic afferent excitability,
in part through modulation of TRPV1 (Perez-Burgos et al.,
2015) and calcium-activated potassium channels in AH neurons
(Kunze et al., 2009). Although the active metabolite(s) from
Lactobacillus reuteri has not been clearly characterized, this
microorganism is a potent producer of histamine; an important
neurotransmitter associated with pathology in the intestine
where it regulates immune function, motility, permeability,
and secretion (Hemarajata and Versalovic, 2013). Naturally,
antibiotic resistant Lactobacilliaceae in patients may therefore be
associated with elevated histamine signaling. Similarly, depletion
of short chain fatty acid producing bacteria in patients receiving
broad spectrum antibiotics may exert epigenetic signals on
enteric neurons and glia that result in altered immune responses,
intestinal motility and luminal pH. Bacterial signals also target
enteric vagal and spinal innervation, although excitability
appears to be more species restricted (Bienenstock et al., 2015).
Environmental stressors also impact the host’s ability to
regulate intestinal physiology, e.g., immune surveillance of the
gut microbiota is modulated by autonomic nervous system
control of bacterial translocation from the colon. Although an
expansive literature demonstrated stress-induced alterations to
intestinal permeability and related activation of mast, neuronal
and glial cells in the gut wall (Lomax et al., 2010; Collins et al.,
2012; Dinan and Cryan, 2012; Furness, 2012; Hemarajata and
Versalovic, 2013; McVey Neufeld et al., 2013; Simrén et al.,
2013; Sharkey and Savidge, 2014; Bienenstock et al., 2015),
less is known about the direct effects of stress on intestinal
microbial function. Distinct stress-related outcomes can be
associated with central versus enteric signals to the intestinal
microbiota. For example, cold stress in humans inducesmast cells
to release histamine in the small intestine (Santos et al., 1998);
whereas central nervous system administration of a thyrotropin
releasing hormone analog—a central effector to cold stress—
induces serotonin release into the gastric lumen (Stephens and
Tache, 1989). Environmental stressors also act on gut-microbiota
interactions via the hypothalamic pituitary adrenal axis which is
a known regulator of gut microbiota composition and function.
Thus, altered microbiota composition and diversity associated
with dietary, environmental or psychological stressors may
contribute directly to intestinal-related disease, and subsequently
may modulate autonomic output by changing the brain’s
response to environmental and internal stimuli, for example via
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intestinal synaptic signaling that interconnects primary intrinsic
afferents with the vagus nerve (Perez-Burgos et al., 2015). This
may potentially lead to a maladaptive cycle of psychological and
psychiatric disorders that are often associated with intestinal
disease e.g., autism spectrum disorders and Parkinson’s disease. It
is interesting to note that gut microbiota-derived metabolites are
now also implicated in the development and function of central
and other peripheral nervous systems, but these observations fall
beyond the scope of this mini-review.
CONCLUSIONS
An emerging concept in intestinal disease associated with enteric
neuropathy is that microbiota signals can mediate some of the
effects, whether beneficial or detrimental. Preliminary studies
implicate the enteric nervous system as an important regulatory
signal of intestinal microbial community structure and function.
Microbial communities themselves are prone to epigenetic
signals that are associated with disease and may contribute to the
disease pathogenesis by eliciting neurotransmitter profiles that
interfere with enteric nervous system homeostasis. Microbial-
derived neurotransmitters include regulators such as serotonin,
histamine and catecholamines that operate in a coordinated
manner with bacterial gaseous transmitters—hydrogen sulfide
and nitric oxide—which are being independently pursued as
intestinal therapeutics (Savidge, 2014). Careful examination of
cross-regulatory circuits between the enteric nervous system
and microbial neurotransmission needs to be conducted to
assess whether a combinatorial therapeutic approach may
prove more effective in enteric neuropathy. Manipulation of
the gut microbiota offers a relatively unexplored strategy
for therapeutically targeting intestinal disease and will likely
generate an extensive repertoire of druggable targets that do
not interfere with host nervous systems. Future work needs
to characterize the specific bacterial neurotransmitters that
synergize or counterbalance signals emanating from autonomic
and central nervous systems.
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